Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Semaglutide, the active ingredient of both oral and injectable Wegovy, copies GLP-1
The molecule's backbone is derived from the native human glucose-dependent insulinotropic polypeptide (GIP) sequence, with engineered modifications that add GLP-1 receptor agonist activity to the GIP-receptor activation native to the parent sequence
Your doctor will assess your history before prescribing
They can discuss the potential benefits and risks of the medication with you and advise on the appropriate dose
Those experiencing unexplained symptoms, skin reactions, or signs of hypoglycaemia (dizziness, sweating, confusion) should seek prompt medical attention
Results Between January 1, 2016, and July 17, 2025, a total of 1,515 adult patients with T2DM who were prescribed a GLP-1 receptor agonist were screened
US$ 27.28
US$ 29.44
US$ 25.67
US$ 27.37
